Operationalization and Use of Bispecific T-Cell-Engaging Antibodies in Community Practices: Multidisciplinary Perspectives on Developing Logistics and Workflow for Cytokine Release Syndrome Management.

William Donnellan, Shih-Wen Lin, Jonathan Abbas, Jesus G Berdeja, Lourenia Cassoli, Jason C Chandler, Brannon Flores, Sara Hall, Arliene Ravelo, Anthony Masaquel, Sharifa Patterson, Eileen Peng, Ashley Todd, Chelsea Traughber, Lisa Raff
{"title":"Operationalization and Use of Bispecific T-Cell-Engaging Antibodies in Community Practices: Multidisciplinary Perspectives on Developing Logistics and Workflow for Cytokine Release Syndrome Management.","authors":"William Donnellan, Shih-Wen Lin, Jonathan Abbas, Jesus G Berdeja, Lourenia Cassoli, Jason C Chandler, Brannon Flores, Sara Hall, Arliene Ravelo, Anthony Masaquel, Sharifa Patterson, Eileen Peng, Ashley Todd, Chelsea Traughber, Lisa Raff","doi":"10.6004/jadpro.2025.16.7.19","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Operationalizing workflows to manage cytokine release syndrome (CRS) in community practices presents challenges for multidisciplinary teams. Real-world experience was gathered from OneOncology community health-care professionals to establish best-prac-tice workflows for CRS management.</p><p><strong>Methods: </strong>Qualitative data were gathered via focus groups from hematology-oncology MDs, PharmDs, and nurse providers (<i>N</i> = 13) with experience treating patients with bispecific T-cell-engaging antibodies (BsAbs). Theme matrix techniques facilitated analysis.</p><p><strong>Results: </strong>Three themes were identified: (1) creating a coordinated workflow plan, (2) building network partnerships, and (3) understanding patient support. Workflow decisions were driven by community practices managing patients treated with BsAbs or partnering with sites for initial dosing and maintenance. Catalysts for developing CRS workflows included: FDA approval of BsAbs; BsAbs clinical trial experience; BsAbs on formulary; having patients receiving BsAbs; and practice champion(s) for protocol development. Key steps included defining communication during and after practice hours, designating training leads, and creating practice-specific plans for interdisciplinary team coordination. Inpatient admission processes developed with hospital staff and hospital staff training were fundamental for successful patient management. Communication processes among practice, pharmacy, and hospital staff throughout BsAbs treatment were established, along with methods to ensure the availability of CRS treatment if needed. Continuous patient/caregiver education on BsAbs treatment, monitoring for adverse events (particularly CRS), and how/when to access care were described.</p><p><strong>Conclusions: </strong>BsAb use in community settings requires multidisciplinary coordination between practices and hospitals. Actions included identifying practice champions, establishing clear workflows for transitioning patients between inpatient and outpatient settings, and ensuring continuous training of staff, patients, and caregivers.</p>","PeriodicalId":94110,"journal":{"name":"Journal of the advanced practitioner in oncology","volume":" ","pages":"1-9"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323733/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the advanced practitioner in oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6004/jadpro.2025.16.7.19","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Operationalizing workflows to manage cytokine release syndrome (CRS) in community practices presents challenges for multidisciplinary teams. Real-world experience was gathered from OneOncology community health-care professionals to establish best-prac-tice workflows for CRS management.

Methods: Qualitative data were gathered via focus groups from hematology-oncology MDs, PharmDs, and nurse providers (N = 13) with experience treating patients with bispecific T-cell-engaging antibodies (BsAbs). Theme matrix techniques facilitated analysis.

Results: Three themes were identified: (1) creating a coordinated workflow plan, (2) building network partnerships, and (3) understanding patient support. Workflow decisions were driven by community practices managing patients treated with BsAbs or partnering with sites for initial dosing and maintenance. Catalysts for developing CRS workflows included: FDA approval of BsAbs; BsAbs clinical trial experience; BsAbs on formulary; having patients receiving BsAbs; and practice champion(s) for protocol development. Key steps included defining communication during and after practice hours, designating training leads, and creating practice-specific plans for interdisciplinary team coordination. Inpatient admission processes developed with hospital staff and hospital staff training were fundamental for successful patient management. Communication processes among practice, pharmacy, and hospital staff throughout BsAbs treatment were established, along with methods to ensure the availability of CRS treatment if needed. Continuous patient/caregiver education on BsAbs treatment, monitoring for adverse events (particularly CRS), and how/when to access care were described.

Conclusions: BsAb use in community settings requires multidisciplinary coordination between practices and hospitals. Actions included identifying practice champions, establishing clear workflows for transitioning patients between inpatient and outpatient settings, and ensuring continuous training of staff, patients, and caregivers.

双特异性t细胞参与抗体在社区实践中的运作和使用:细胞因子释放综合征管理的多学科视角发展物流和工作流程。
目的:在社区实践中实施管理细胞因子释放综合征(CRS)的工作流程对多学科团队提出了挑战。从OneOncology社区卫生保健专业人员那里收集了实际经验,以建立CRS管理的最佳实践工作流程。方法:通过血液肿瘤学医学博士、药学博士和护理人员(N = 13)的焦点小组收集定性数据,这些人员具有治疗双特异性t细胞结合抗体(BsAbs)患者的经验。主题矩阵技术促进了分析。结果:确定了三个主题:(1)创建协调的工作流程计划,(2)建立网络合作伙伴关系,(3)了解患者支持。工作流程决策是由管理接受bsab治疗的患者的社区实践或与站点合作进行初始剂量和维护驱动的。开发CRS工作流程的催化剂包括:FDA批准bsab;有bsab临床试验经验;关于配方的bsab;患者接受bsab;以及协议开发的实践冠军。关键步骤包括在练习时间内和之后定义沟通,指定培训领导,以及为跨学科团队协调创建具体的练习计划。与医院工作人员和医院工作人员培训一起制定的住院住院流程是成功管理患者的基础。在整个bsab治疗过程中,建立了实践、药房和医院工作人员之间的沟通流程,以及确保在需要时提供CRS治疗的方法。对患者/护理人员进行持续的bsab治疗教育,监测不良事件(特别是CRS),以及如何/何时获得护理。结论:在社区环境中使用BsAb需要实践和医院之间的多学科协调。行动包括确定实践冠军,为住院和门诊之间的患者过渡建立明确的工作流程,并确保对工作人员、患者和护理人员进行持续培训。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信